Radiotherapeutic Modalities and Advancements in the Treatment of Cutaneous Malignancies
Journal of Clinical Medicine · 17.09.2025 · 14 (18) · 6547
DOI: 10.3390/jcm14186547 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 17.09.2025. Verfasst von Noor Malik und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine and Dentistry, University of Lancashire, Preston PR1 2HE, UK. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 138 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Cutaneous malignancies represent the most common cancers worldwide and pose a growing public health burden. While surgical excision remains the primary curative modality, radiotherapy offers an effective adjuvant therapy for high-risk histopathologic features and an established, organ-preserving alternative for patients with inoperable disease or lesions in cosmetically or functionally sensitive sites. Advances in radiotherapeutic techniques, including brachytherapy and proton therapy, have expanded the therapeutic armamentarium, allowing tailored treatment based on tumor depth, extent, and anatomical location. Contemporary evidence highlights favorable local control and toxicity outcomes with modern radiation therapy approaches, yet data remain fragmented, with most studies limited by small cohorts, heterogeneous methodologies, and limited follow-up durations. Furthermore, the role of radiotherapy in complex scenarios, such as perineural invasion, recurrent disease, and previously irradiated fields, continues to evolve. This review synthesizes the current literature on radiotherapeutic management of skin cancer, critically evaluates dosimetric and clinical outcomes across modalities, and identifies key gaps in evidence. Emphasis is placed on the need for prospective, multicenter investigations to better define comparative effectiveness, optimize dose-fractionation regimens, and integrate emerging technologies into clinical practice. Radiotherapy remains an indispensable modality in dermatological oncology, offering curative potential with preservation of cosmesis and function, yet its optimal utilization demands further high-quality research to refine patient selection and therapeutic strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine and Dentistry, University of Lancashire, Preston PR1 2HE, UK.
- New York Proton Center, New York, NY 10035, USA.
- Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
- Department of Radiation Oncology, Mount Sinai Medical Center, New York, NY 10029, USA.
ORCID-Profile: Noor Malik, Irini Yacoub, Kristin Hsieh, Charles B Simone
Förderung
- NCI NIH HHS
Zitieren
APA
Malik, N., Yacoub, I., Hsieh, K., Choi, J. I., Chhabra, A., & Simone, C. B. (2025). Radiotherapeutic Modalities and Advancements in the Treatment of Cutaneous Malignancies. Journal of Clinical Medicine, 14(18), 6547. https://doi.org/10.3390/jcm14186547
Vancouver
Malik N, Yacoub I, Hsieh K, Choi JI, Chhabra A, Simone CB. Radiotherapeutic Modalities and Advancements in the Treatment of Cutaneous Malignancies. Journal of Clinical Medicine. 2025;14(18):6547. doi:10.3390/jcm14186547
BibTeX
@article{Malik2025,
author = {Malik, Noor and Yacoub, Irini and Hsieh, Kristin and Choi, J Isabelle and Chhabra, Arpit and Simone, Charles B},
title = {Radiotherapeutic Modalities and Advancements in the Treatment of Cutaneous Malignancies},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {18},
pages = {6547},
doi = {10.3390/jcm14186547}
}
EUVIMED